[Federal Register Volume 62, Number 139 (Monday, July 21, 1997)]
[Notices]
[Page 39031]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-19021]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (97-097)]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that New Century Pharmaceuticals, 
Inc., of Huntsville, Alabama, has applied for an exclusive license to 
practice the invention described and claimed in NASA Case No. MFS-
28989-1, entitled ``Protein Crystal Growth Apparatus for 
Microgravity,'' which is assigned to the United States of America as 
represented by the Administrator of the National Aeronautics and Space 
Administration. Written objections to the prospective grant of a 
license should be sent to Marshall Space Flight Center.

DATES: Responses to this notice must be received by September 19, 1997.

FOR FURTHER INFORMATION CONTACT: Robert L. Board, Patent Counsel, 
Marshall Space Flight Center, Mail Code CC01, Huntsville, Alabama 
35812, telephone (205) 544-0021, fax (205) 544-0258.

    Dated: July 14, 1997.
Edward A. Frankle,
General Counsel.
[FR Doc. 97-19021 Filed 7-18-97; 8:45 am]
BILLING CODE 7510-01-M